Although overdose deaths from heroin and prescription opioids have declined, deaths involving synthetic opioids are on the rise. Much of the current wave of overdoses is linked to one synthetic opioid: fentanyl.
This article represents the first U.S. study employing exclusively household-level longitudinal data spanning the Great Recession to estimate the response of household spending to negative wealth shocks induced by the sharp declines in house prices.
This paper assesses community perceptions of crime and the police before and after the implementation of an intervention aimed at eliminating overt drug markets through focused deterrence and police-community partnerships emphasizing racial reconciliation.
Bryce Pardo and Beau Kilmer discuss recent trends in U.S. fatal overdoses and drug seizures, factors that have contributed to the rise of synthetic opioids in the U.S., what the future of fentanyl and other synthetic opioids looks like, and traditional and non-traditional policy options for addressing fentanyl problems.
Those at the bottom of the European agricultural supply chain are vulnerable to abuse. The same was true in the tomato fields of Florida until recently. The solution developed there may offer a roadmap for doing right by workers in Europe.
America's fentanyl problem is far deadlier than past crises with other illegal drugs. New ideas, be they public policies, technologies or law enforcement strategies, are desperately needed. Continuing to treat fentanyl just like previous drug epidemics will likely be insufficient and may condemn thousands more to early deaths.
The U.S. overdose crisis worsened dramatically with the arrival of synthetic opioids like fentanyl—now responsible for tens of thousands of deaths annually—and the problem requires innovative new strategies because the epidemic is unlike others that have struck the nation.
The rise of fentanyl and other synthetic opioids is unlike any drug crisis in U.S. history. Limiting policy responses to existing approaches will likely be insufficient and may condemn many people to early deaths.
Spending on cannabis, cocaine, heroin and methamphetamine by Americans reached nearly $150 billion in 2016, with a large proportion of spending coming from the small share of people who use drugs on a daily or near-daily basis.
Americans spent about $150 billion on cannabis, cocaine, heroin, and methamphetamine in 2016—rivaling U.S. spending on alcohol. This number is driven in large part by the small share of people who use drugs on a daily or near-daily basis.
Document submitted on August 19, 2019, as an addendum to testimony before the House Committee on Homeland Security, Subcommittee on Intelligence and Counterterrorism and Subcommittee on Border Security, Facilitation, and Operations on July 25, 2019.
In less than six years, the number of fatal overdoses in the United States that involve synthetic opioids has increased tenfold. Where are synthetic opioids concentrated? And to what extent is the problem spreading?
For busy staff, August's respite from back-to-back meetings, hearing preparation, and late votes is hard-earned. The summer recess also provides an opportunity to get ahead of issues that will resurface in the fall. To that end, we have compiled recent RAND research on topics likely to top the congressional agenda come September.
An overview of testimony by Bryce Pardo presented before the House Committee on Homeland Security, Subcommittee on Intelligence and Counterterrorism and Subcommittee on Border Security, Facilitation, and Operations, on July 25, 2019.